Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,299
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Salt Lake City UT, Seattle WA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase 2, Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase 1, Recruiting
Active & Responsive
Teen and Adult Tic TMS Study
for
Tic Disorder
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 15 - 35
Code: NCT07839377
Recruiting
Active & Responsive
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
for
HSIL, High Grade Squamous Intraepithelial Lesion,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 21+
Code: NCT06949800
Phase 2, Recruiting
Active & Responsive
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: San Francisco CA, Beverly Hills CA, Fullerton CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT07570862
Phase 2, Recruiting
Active & Responsive
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
for
Cirrhosis, Frailty, Sarcopenia
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07029243
Recruiting
Active & Responsive
PVI Alone Versus PVI Plus PWI and SVCI With PFA
for
Persistent Atrial Fibrillation
Location: San Francisco CA
Sponsor: Edward Gerstenfeld, MD
Sex: All
Age: 18+
Code: NCT07405359
Recruiting
Active & Responsive
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for
Type 1 Diabetes
Location: San Francisco CA, Newport Beach CA, Omaha NE,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676565
Recruiting
Active & Responsive
A Gaucher Disease Gene Therapy Trial With FLT201
for
Gaucher Disease Type 1
Location: San Francisco CA, Los Angeles CA, Aurora CO, Calgary,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase 3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase 3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: San Francisco CA, Eugene OR, La Jolla CA, Portland OR,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase 2, Recruiting
Active & Responsive
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
for
Glioblastoma
Location: San Francisco CA, Orange CA, La Jolla CA,
Sponsor: Global Coalition for Adaptive Research
Sex: All
Age: 18+
Code: NCT03970447
Phase 2, Phase 3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: San Francisco CA, Sacramento CA, Carson City NV,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies